Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003

Sexually Transmitted Infections

Volumn 84, Issue 1, 2008, Pages 19-22

  Lyytikainen E ^a,b   Kaasila, M ^a   Koskela, P ^a   Lehtinen, M ^a,d   Patama, T ^c   Pukkala, E ^d   Tasanen, K ^b   Surcel, Heljä Marja ^a   Paavonen, J ^e  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; WART VIRUS;

ADULT; ANTIBODIES, BACTERIAL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; FINLAND; HUMANS; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROEPIDEMIOLOGIC STUDIES;

EID: 38849123536     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2007.027409     Document Type: Article

References (16)

1. World Health Organization. Global prevalence and incidence of selected available sexually transmitted infections, 2001. http://www.who.int/ docstore/hiv/GRSTI/003.htm. (accessed Oct 2007).
2. Stamm WE. Chlamydia trachomatis infections: progress and problems. J Infect Dis 1999;179(Suppl 2):380-3.
3. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update 1999;5:433-47.
4. Koskela P, Anttila T, Bjorge T, et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000;85:35-9.
5. Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001;285:47-51.
6. The Statistical Database of the Infectious Diseases Register. http://www3.ktl.fi/. (accessed Oct 2007).
7. Paukku M, Kilpikari R, Puolakkainen M, et al. Criteria for selective screening for Chlamydia trachomatis. Sex Transm Dis 2003;30:120-3.
8. Land JA, Gijsen AP, Kessels AG, et al. Performance of five serological chlamydia antibody tests in subfertile women. Hum Reprod 2003;18:2621-7.
9. Lehtinen M, Kaasila M, Pasanen K, et al. Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s. Int J Cancer 2006;119:2612-19.
10. Pukkala E. Cancer maps of Finland: an example of small area-based mapping. Recent Results Cancer Res 1989;114:208-15.
11. Wilson JS, Honey E, Templeton A, et al. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update 2002;8:385-94.
12. Kibur M, Koskela P, Dillner J, et al. Seropositivity to multiple sexually transmitted infections is not common. Sex Transm Dis 2000;27:425-30.
13. Smith JS, Munoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002;185:324-31.
14. Yamamoto T, Moji K, Kusano Y, et al. Trend in Chlamydia trachomatis infection among pregnant women in the past ten years in Japan: significance of Chlamydia trachomatis seroprevalence. Sex Transm Dis 1998;25:516-21.
15. Laukkanen P, Koskela P, Pukkala E, et al. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol 2003;84:2105-9.
16. Brunham RC, Pourbohloul B, Mak S, et al. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005;192:1836-44.